<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04115605</url>
  </required_header>
  <id_info>
    <org_study_id>SU017</org_study_id>
    <nct_id>NCT04115605</nct_id>
  </id_info>
  <brief_title>A 3 Years Naturalistic Cohort Survey of Altis Single Incision Sling System For Female Stress Urinary Incontinence</brief_title>
  <official_title>A 3 Years Naturalistic Cohort Survey of Altis Single Incision Sling System For Female Stress Urinary Incontinence A Post-marketing and Multicenter Prospective Observational Cohort Study in Subjects With Female Stress Urinary Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to monitor the use of Altis Single Incision Sling (SIS) in a
      real world population and collect medical data on effectiveness and to monitor safety of
      Altis SIS at 12 and 36 months post device implantation in women with stress urinary
      incontinence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project has been launched after the introduction of Altis in Europe. This study is a
      multicenter prospective, observational (i.e. naturalistic) post-marketing clinical follow-up
      of women for who stress urinary incontinence was diagnosed and will be treated with Altis
      Single Incision Sling System. Therefore these patients will be asked to allow to use their
      clinical data and answer some questionnaires. The patients'data will be collected in routine
      clinical practice before, during and after surgery until 12 months. Then, questionnaires will
      be mailed to the participants annually during 2 additional years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 27, 2015</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Patient Global Impression of Improvement (PGI-I)</measure>
    <time_frame>12 months</time_frame>
    <description>PGI-I is a validated question that collects the patient's impression of improvement after the surgery. Among this 7 point-scale (very much better, much better, a little better, no change, a little worse, much worse and very much worse), the patients are asked to check the one number that describes how their urinay tract condition is now, compared with how it's was before the surgery. Patients who score little or much or very much better will be considered a treatment success. The percentage of patients who describe the treatment success is measured</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse events</measure>
    <time_frame>12 months</time_frame>
    <description>Adverse events are any toward medical occurrence, unintended disease or injury or any untoward clinical signs in subjects. Adverse events will be categorized according to relatedness to device or procedure, severity and frequency. At 12-months, The percentage of patients without any device related severe or serious adverse events is measured.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cough stress test (CST)</measure>
    <time_frame>Baseline, 8 weeks and 12 months</time_frame>
    <description>CST provides the means for documenting stress urinary incontinence. CST is considered &quot;positive&quot; if any leakage is noted with cough or valsava. The percentage of patients with positive and negative test will be calculated at baseline, at the post-operative visit and at one year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-void residual (PVR) volume</measure>
    <time_frame>Baseline, 8 weeks and 12 months</time_frame>
    <description>PVR volume will be collected pre- and post implant procedure up to 12 months. If the PVR volume is considered normal by the physician after the procedure it is not necessary to collect these data at the subsequent follow-up visits.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pad Use</measure>
    <time_frame>Baseline, 8 weeks, 12, 24 and 36 months</time_frame>
    <description>The number of pads used will be collected. Patients will be considered to be pad free if they report never wearing pads or wear pads just for a sense of security.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Consultation on Incontinence Questionnaire (ICIQ-UI)</measure>
    <time_frame>Baseline, 8 weeks, 12, 24 and 36 months</time_frame>
    <description>The ICIQ-UI Short Form is a seft-administred questionnaire to evaluate the frequency, severity and impact on quality of life of urinary incontinence. Question 1 asked, &quot;How often do you leak urine?&quot; Subjects were instructed to select among &quot;none&quot; (0), &quot;about once a week or less often&quot; (1), &quot;2 or 3 times a week&quot; (2), &quot;about once a day&quot; (3), &quot;several times a day&quot; (4), and &quot;all the time&quot; (5). Question 2 asked, &quot;How much urine do you usually leak (whether you wear protection or not)?&quot; Patients responded with &quot;none&quot; (0), &quot;a small amount&quot; (2), &quot;a moderate amount&quot; (4) or &quot;a large amount (6). Question 3 asked, &quot;Overall, how much does leaking urine interfere with your everyday life?&quot; Participants chose a number from 0 (not at all) to 10 (a great deal). Question 1, 2 and 3 are summed to compute the total ICIQ score.The total score range is then a minimum of 0 to a maximum of 21. The mean score, aboslute and relative change compared to baseline will be measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject global satisfaction questionnaire</measure>
    <time_frame>8 weeks, 12, 24, 36 months</time_frame>
    <description>This non-validated questionnaire provides additional information concerning patient satisfaction. This survey consists of two questions: Question 1 &quot;how satisfied are you with your surgery?&quot;. Among 5 point-scale (very satisfied, satisfied, not satisfied-not dissatisfied, dissatisfied and very dissatified), patient check the one items that best describes the subject satisfaction. We measure the percentage the patients who very satisfied and satisfied. The patients answer the question &quot;Do you recommend this operation to a friend?&quot; by &quot;yes&quot; or &quot;no&quot;. We measure the percentage of patients who answer &quot;yes&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incontinence quality of life questionnaire (I-QoL)</measure>
    <time_frame>Baseline, 8 weeks, 12, 24, 36 months</time_frame>
    <description>The Incontinence quality of life questionnaire (I-QoL) is a validated survey questionnaire with 22 items that are scored on a 5-point Likert scale. The I-QOL ans its subcale scores are computed by adding each item's reponse, subtracting the lowest possible score and diving that sum by the possible raw score range. The scores are then transformed to have a range from 0 (maximum problem) to 100 (no problem at all). The mean score, absolute and relative change compared to baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact on sexual function assessed by the Pelvic organ/urinary incontinence sexual questionnaire (PISQ 12)</measure>
    <time_frame>Baseline, 8 weeks, 12, 24, 36 months</time_frame>
    <description>The Pelvic organ/urinary incontinence sexual questionnaire (PISQ-12) is a validated and reliable short form questionnaire including 12 questions that evaluates sexual function in heterosexual women with urinary incontinence and/or pelvic oragn prolapse. Reponses are graded on a 5-point Likert scale from &quot;never&quot; to &quot;always&quot;. The scores will be calculated at each assessment visit. The mean score, absolute and relative change compared to baseline</description>
  </secondary_outcome>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Urinary Incontinence, Stress</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Altis Single Incision Sling</intervention_name>
    <description>Minimally invasive system including permanently implantable synthetic suburethral sling for the surgical treatment of female Stress Urinary Incontinence</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Female implanted with Altis Single Incision Sling System to treat stress urinary
        incontinence
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Implanted with Altis Single Incision Sling System

        Exclusion Criteria:

          -  Refuses to be included in the survey or that their medical data will be used for
             research purposes

          -  Indication for Altis Single Incision Sling System implantation is not for the
             treatment of female urinary incontinence.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Grégoire Capon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Pellegrin, Bordeaux, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hugo Ryckebusch, MD</last_name>
    <phone>+33 1 40 83 68 52</phone>
    <email>frhr@coloplast.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Martine Dehez</last_name>
    <phone>+33 9 83 54 12 45</phone>
    <email>frmdeh@coloplast.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Van der Aa, Pr</last_name>
    </contact>
    <investigator>
      <last_name>Frank Van Der Aa, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susanne Houssmans, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Hotel Dieu</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Phillippe Descamps, Pr</last_name>
    </contact>
    <investigator>
      <last_name>Laurent Catala, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Phillippe Descamps, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Rhône Durance</name>
      <address>
        <city>Avignon</city>
        <zip>84082</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacques Wodey, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Pellegrin-Urology Departement</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregoire Capon, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Gregoire Capon, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Pellegrin_Gyneacology Departement</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claude Hocke, Pr</last_name>
    </contact>
    <investigator>
      <last_name>Claude Hocke, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Polyclinique Jean Villars</name>
      <address>
        <city>Bruges</city>
        <zip>33523</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Jourdain, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Champeau Mediterranée</name>
      <address>
        <city>Béziers</city>
        <zip>34535</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georges Eglin, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Georges Eglin, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maximes Ondedieu, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital du Pays d'Autan</name>
      <address>
        <city>Castres</city>
        <zip>81108</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric Mignot, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pôle Santé Léonard de Vinci</name>
      <address>
        <city>Chambray-lès-Tours</city>
        <zip>37170</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Janin, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Patrick Janin, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Clermont Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loiseau Campagne, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Loiseau Campagne, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra Curinier, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Revaz Botchorishvili, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Victor Jousselin</name>
      <address>
        <city>Dreux</city>
        <zip>28102</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Talal Abdelkader, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Sainte Marguerite</name>
      <address>
        <city>Hyères</city>
        <zip>83400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH Paul Ardier</name>
      <address>
        <city>Issoire</city>
        <zip>63503</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aslam Mansoor, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Aslam Mansoor, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Saint-Charles</name>
      <address>
        <city>La Roche sur Yon</city>
        <zip>85106</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascale Tardivel, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Saint Louis</name>
      <address>
        <city>La Rochelle</city>
        <zip>17019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Ferry, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique du Mail La Rochelle</name>
      <address>
        <city>La Rochelle</city>
        <zip>17087</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Drapier, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Saint-Amé</name>
      <address>
        <city>Lambres lez douai</city>
        <zip>59552</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric Dedecker, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique des Ormeaux</name>
      <address>
        <city>Le Havre</city>
        <zip>76600</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH Libourne</name>
      <address>
        <city>Libourne</city>
        <zip>33500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Briex, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Michel Briex, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Mutualiste de la Porte de l'Orient</name>
      <address>
        <city>Lorient</city>
        <zip>56100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Pierre Graziana, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Jean Pierre Graziana, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascal Simon, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital privé Jacques Cartier</name>
      <address>
        <city>Massy</city>
        <zip>91349</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Athmane safsaf, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Armand Brillart Hospital</name>
      <address>
        <city>Nogent-sur-Marne</city>
        <zip>94130</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Traiman, Dr</last_name>
    </contact>
    <investigator>
      <last_name>David Traiman, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Mutualiste Henri Malartic</name>
      <address>
        <city>Ollioules</city>
        <zip>83192</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital saint Louis</name>
      <address>
        <city>Paris</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHI Poissy Saint Germain en Laye</name>
      <address>
        <city>Poissy</city>
        <zip>78303</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georges Bader, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique St Hilaire Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Centre Clinical</name>
      <address>
        <city>Soyaux</city>
        <zip>16800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gauthier D'Halluin, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Jean Languedoc</name>
      <address>
        <city>Toulouse</city>
        <zip>31077</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Tollon, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Ambroise Paré</name>
      <address>
        <city>Toulouse</city>
        <zip>31082</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie Berrogan, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Nathalie Berrogan, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jaqueline Sagasser, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Jaqueline Sagasser, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Angelika Mattmer, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabian Garrido, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sozialstiftung Bamberg</name>
      <address>
        <city>Bamberg</city>
        <zip>96049</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Schroder, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Jan Schroder, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephanie Harrer, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Memmingen</name>
      <address>
        <city>Memmingen</city>
        <zip>87700</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felix Flock, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Felix Flock, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kathrin Mühlen, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Worms gGmbH</name>
      <address>
        <city>Worms</city>
        <zip>67550</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rainer Lange, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Rainer Lange, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jessica Geye, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda USL Valle d'Aosta</name>
      <address>
        <city>Aosta</city>
        <zip>11100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandro Benvenuti</last_name>
    </contact>
    <investigator>
      <last_name>Sandro Benvenuti, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ezio Talarico, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Luis Poza Barrasus, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Jose Luis Poza Barrasus, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jordi Sabadell, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nuria Rodriquez Mias, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sabina Salicru, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anabel Montero, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Univeritario Joan XXIII</name>
      <address>
        <city>Tarragona</city>
        <zip>43005</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prados Saavedra Manel, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Prados Saavedra Manel, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xavier Ruiz Plazas, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Segarra Tomas, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Helena Ascaso Til, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital la Fé</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francisco Nohales Alfonso, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Francisco Nohales Alfonso, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Celia Bauset, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marta Garcia-Gamon, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hosital Clinico de Valladolid</name>
      <address>
        <city>Valladolid</city>
        <zip>47003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Ignacio Gonzalez, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Jose Ignacio Gonzalez, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sonia De Miguel, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Esther Valsero, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Bedate, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gala Melgar, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabel Molperes, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>July 23, 2015</study_first_submitted>
  <study_first_submitted_qc>October 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2019</study_first_posted>
  <last_update_submitted>November 21, 2019</last_update_submitted>
  <last_update_submitted_qc>November 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Single Incision Sling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

